Contact Trilogie or Request a Consultation

Have a project in mind? Need to validate an E3 ligase or optimize protein expression?

We’re scientists first, and we’re here to help you move faster, with confidence.

Fill-in the form with your question, order inquiries or consultation request and we’ll get back to you within 1 business day.

About Trilogie

High Specific Activity UPS Reagents: Discovery Begins with Functional Precision

Trilogie was founded to solve a critical gap in ubiquitin-proteasome system (UPS) research: the paucity of high-specific-activity, biologically validated reagents and services that reflect the true complexity of UPS biology. Whether you’re mapping E3-substrate interactions, screening DUB inhibitors, or engineering protein degraders, we believe experimental outcomes depend on functional precision, starting with the reagents themselves.

Our focus:

  • Expression scouting and optimization for ligases, substrates, adaptors, and complex UPS proteins
  • Mechanism-aligned assay development for ubiquitylation cascades and degrader mode-of-action studies
  • Growing catalog of ready-to-use UPS tools designed to support academic and drug discovery researchers with reagents that perform reliably

Design, expression optimization, and production are conducted at our Worcestor, MA facility

Leadership

Peter Li, PhD
Chief Executive Officer and Co-Founder

Bradley Brasher, PhD
Chief Scientific Officer and Co-Founder

Jean Qiu, PhD
Chief Business Officer and Co-Founder